Stock Earnings

Question 1

Quels sont les états financiers clés de Cidara Therapeutics Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Cidara Therapeutics Inc a un total d'actifs de $214, un bénéfice net loss de $-169

Question 2

Quels sont les ratios financiers clés pour CDTX ?

Accepted Answer

Le ratio de liquidité de Cidara Therapeutics Inc est 4.19, la marge nette est -16,900, les ventes par action sont de $0.15.

Question 3

Comment les revenus de Cidara Therapeutics Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Cidara Therapeutics Inc largest revenue segment is Drug-Fc conjugate, at a revenue of 1,275,000 in the most earnings release.For geography, United States is the primary market for Cidara Therapeutics Inc, at a revenue of 1,275,000.

Question 4

Cidara Therapeutics Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Cidara Therapeutics Inc a un bénéfice net loss de $-169

Question 5

Cidara Therapeutics Inc a-t-elle des passifs ?

Accepted Answer

yes, Cidara Therapeutics Inc a un passif de 51

Question 6

Combien d'actions en circulation Cidara Therapeutics Inc a-t-elle ?

Accepted Answer

Cidara Therapeutics Inc a un total d'actions en circulation de 10.94

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	1	63	64	49	12
Revenue Growth (YoY)	-100%	-98%	-2%	31%	308%	-40%
Cost of Revenue	--	--	1	0	--	--
Gross Profit	--	--	62	64	--	--
Selling, General & Admin	24	20	18	20	18	15
Research & Development	108	71	68	77	73	68
Operating Expenses	124	92	86	97	91	83
Other Non Operating Income (Expenses)	0	--	--	--	--	--
Pretax Income	-117	-170	-22	-33	-42	-72
Income Tax Expense	--	0	0	0	--	--
Net Income	-117	-169	-22	-33	-42	-74
Net Income Growth	2%	668%	-33%	-21%	-43%	80%
Shares Outstanding (Diluted)	15.54	6.34	4.37	3.49	2.62	2.07
Shares Change (YoY)	241%	45%	25%	33%	26%	43%
EPS (Diluted)	-7.55	-26.74	-5.25	-9.61	-16.19	-36.03
EPS Growth	-70%	409%	-45%	-41%	-55%	28%
Free Cash Flow	-129	-176	-22	-28	-25	-54
Free Cash Flow Per Share	-8.29	-27.71	-5.03	-8.01	-9.53	-25.98
Gross Margin	--	--	98.41%	100%	--	--
Operating Margin	0%	-9,100%	-38.09%	-51.56%	-85.71%	-591.66%
Profit Margin	0%	-16,900%	-34.92%	-51.56%	-85.71%	-616.66%
Free Cash Flow Margin	0%	-17,600%	-34.92%	-43.75%	-51.02%	-450%
EBITDA	-124	-91	-24	-33	-42	-71
EBITDA Margin	0%	-9,100%	-38.09%	-51.56%	-85.71%	-591.66%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-124	-91	-24	-33	-42	-71
EBIT Margin	0%	-9,100%	-38.09%	-51.56%	-85.71%	-591.66%
Effective Tax Rate	--	0%	0%	0%	--	--

Cidara Therapeutics Inc (CDTX) Price

CDTX Stock Price Chart

CDTX Income

Follow-Up Questions